Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Атмосфера. Новости кардиологии
2020 / N 4

“Вместе мы можем больше” – использование фиксированной комбинации β-адреноблокатора бисопролола и ингибитора ангиотензинпревращающего фермента периндоприла аргинина в лечении больных с артериальной гипертонией
И.А. Либов, Ю.Н. Моисеева, О.В. Кондрашов

References

1. Franklin SS, Lopez VA, Wong ND, Mitchell GF, Larson MG, Vasan RS, Levy D. Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study. Circulation 2009 Jan;119(2):243-50.
2. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; Authors/Task Force Members. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Journal of Hypertension 2018 Oct;36(10):1953-2041.
3. Kobalava ZhD, Konradi AO, Nedogoda S, Shlyakhto EV, Arutyunov GP, Baranova EI, Barbarash OL, Boytsov SA, Vavilova TV, Villevalde SV, Galyavich AS, Glezer MG, Grineva EN, Grinstein YuI, Drapkina OM, Zhernakova YuV, Zvartau NE, Kislyak OA, Koziolova NA, Kosmacheva ED, Kotovskaya YuV, Libis RA, Lopatin YuM, Nebiyeridze DV, Nedoshivin AO, Ostroumova OD, Oshchepkova EV, Ratova LG, Skibitskiy VV, Tkacheva ON, Chazova IE, Chesnikova AI, Chumakova GA, Shalnova SA, Shestakova MV, Yakushin SS, Yanishevskiy SN. Arterial hypertension in adults: clinical guidelines 2020. Russian Journal of Cardiology 2020;25(3):149-218 (In Russian).
4. Gillman MW, Kannel WB, Belanger A, D’Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham study. American Heart Journal 1993 Apr;125(4):1148-54.
5. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001 Sep;104(13):1477-82.
6. Barbarash OL, Karpov YuA, Kashtalap VV, Boshchenko AA, Ruda MM, Akchurin RS, Alekyan BG, Aronov DM, Belenkov YuN, Boytsov SA, Bolduyeva SA, Bubnova MG, Vasyuk YuA, Gabinskiy YaL, Galyavich AS, Glezer MG, Golubev EP, Golukhova EZ, Grinstein YuI, Davidovich IM, Yezhov MV, Karpov RS, Korennova OYu, Kosmacheva ED, Koshelskaya OA, Kukharchuk VV, Lopatin YuM, Mironov VM, Martsevich SY, Mirolyubova OA, Mikhin VP, Nedoshivin AO, Oleynikov VE, Panov AV, Panchenko EP, Perepech NB, Petrova MM, Pozdnyakov YuM, Protasov KV, Savenkov MP, Samko AN, Skibitskiy VV, Soboleva GN, Shalayev SV, Shaposhnik II, Shevchenko AO, Shevchenko OP, Shiryaev AA, Shlyakhto EV, Chumakova GA, Yakushin SS. 2020 Clinical practice guidelines for stable coronary artery disease. Russian Journal of Cardiology 2020;25(11):201-50 (In Russian).
7. Chen XJ, Barywani SB, Barywani PO, Thunström EÖ, Rosengren A, Ergatoudes C, Mandalenakis Z, Caidahl K, Fu ML. Impact of changes in heart rate with age on all-cause death and cardiovascular events in 50-year-old men from the general population. Open Heart 2019 Apr;6(1):e000856.
8. Thomopoulos C, Bazoukis G, Tsioufis C, Mancia G. Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials. Journal of Hypertension 2020 Sep;38(9):1669-81.
9. van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, Boersma E. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients. European Heart Journal 2012 Aug;33(16):2088-97.
10. Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. The Cochrane Database of Systematic Reviews 2012 Dec;12:CD004136.
11. Baker WL, Coleman CI, Kluger J, Reinhart KM, Talati R, Quercia R, Phung OJ, White CM. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease. Annals of Internal Medicine 2009 Dec;151(12):861-71.
12. Savarese G, Costanzo P, Cleland JG, Vassallo E, Ruggiero D, Rosano G, Perrone-Filardi P. A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure. Journal of the American College of Cardiology 2013 Jan;61(2):131-42.
13. Fox KM; EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). The Lancet 2003 Sep;362(9386):782-8.
14. Sleight P. The HOPE study (Heart Outcomes Prevention Evaluation). Journal of the Renin-Angiotensin-Aldosterone System 2000 Mar;1(1):18-20.
15. Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL; PEACE Trial Investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. The New England Journal of Medicine 2004 Nov;351(20):2058-68.
16. Pitt B, O’Neill B, Feldman R, Ferrari R, Schwartz L, Mudra H, Bass T, Pepine C, Texter M, Haber H, Uprichard A, Cashin-Hemphill L, Lees RS; QUIET Study Group. The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. The American Journal of Cardiology 2001 May;87(9):1058-63.
17. Kotseva K, Wood D, De Bacquer DD, De Backer G, Rydén L, Jennings C, Gyberg V, Amouyel P, Bruthans J, Conde AC, Cífková R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Miličić D, Moore D, Nicolaides E, Oganov R, Pajak A, Pogosova N, Reiner Z, Stagmo M, Störk S, Tokgözoğlu L, Vulic D; EUROASPIRE Investigators. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. European Journal of Preventive Cardiology 2016 Apr;23(6):636-48.
18. Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D, Maggioni A, Marques-Vidal P, Jennings C, Abreu A, Aguiar C, Badariene J, Bruthans J, Castro Conde A, Cifkova R, Crowley J, Davletov K, Deckers J, De Smedt D, De Sutter J, Dilic M, Dolzhenko M, Dzerve V, Erglis A, Fras Z, Gaita D, Gotcheva N, Heuschmann P, Hasan-Ali H, Jankowski P, Lalic N, Lehto S, Lovic D, Mancas S, Mellbin L, Milicic D, Mirrakhimov E, Oganov R, Pogosova N, Reiner Z, Stöerk S, Tokgözoğlu L, Tsioufis C, Vulic D, Wood D; EUROASPIRE Investigators. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. European Journal of Preventive Cardiology 2019 May;26(8):824-35.
19. Brugts JJ, Bertrand M, Remme W, Ferrari R, Fox K, MacMahon S, Chalmers J, Simoons ML, Boersma E. The treatment effect of an ACE-inhibitor based regimen with perindopril in relation to beta-blocker use in 29,463 patients with vascular disease: a combined analysis of individual data of ADVANCE, EUROPA and PROGRESS trials. Cardiovascular Drugs and Therapy 2017 Aug;31(4):391-400.
20. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008 May;336(7653):1114-7.
21. Rea F, Cantarutti A, Merlino L, Ungar A, Corrao G, Mancia G. Antihypertensive treatment in elderly frail patients: evidence from a large Italian database. Hypertension (Dallas, Tex.: 1979) 2020 Aug;76(2):442-9.
22. Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, Schwartz JS. Predictors of adherence with antihypertensive and lipid-lowering therapy. Archives of Internal Medicine 2005 May;165(10):1147-52.
23. Madej A, Buldak L, Basiak M, Szkrobka W, Dulawa A, Okopien B. The effects of 1 month antihypertensive treatment with perindopril, bisoprolol or both on the ex vivo ability of monocytes to secrete inflammatory cytokines. International Journal of Clinical Pharmacology and Therapeutics 2009 Nov;47(11):686-94.
24. Lutai MI, Golikova IP. The effectiveness of treatment of patients with stable coronary heart disease and concomitant hypertension: the results of a multicenter study PRESTOL. Ukrainian Journal of Cardiology 2019;26(1):19-30.
  

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]